✦ LIBER ✦

Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma

✍ Scribed by C. Haie-Meder; A. Kramar; P. Lambin; R. Lancar; P. Scalliet; J. Bouzy; A. Gerbaulet

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 931 KB
Volume: 29
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(94)90388-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of late effects of a randomized

Analysis of late effects of a randomized trial comparing two low dose rates in cervix cancer brachytherapy

✍ C. Haie-Meder; A. Kramar; P. Lambin; R. Lancar; P. Scalliet; J. Bouzy; A. Gerbau 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Phase III trial comparing two low dose r

Phase III trial comparing two low dose rates in brachytherapy of cervix carcinoma: Report at two years

✍ Philippe Lambin; Alain Gerbaulet; Andrew Kramar; Pierre Scalliet; Christine Haie 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

An analysis of the efficacy and safety o

An analysis of the efficacy and safety of high dose rate as compared to low dose rate brachytherapy in the treatment of uterine cervical carcinoma

✍ Trudy J. Hartmann; Jann N. Sarkaria; Daniel G. Petereit; Judith A. Stitt; Dolore 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 123 KB

1001 Comparison of two low-dose rates in

1001 Comparison of two low-dose rates in vaginal prophylactic pre-operatne (PO) brachytherapy (BT) for stage I–II endometriai carcinoma results of a randomized trial

✍ C. Haie-Meder; A. Kramar; D. Castaigne; P. Lambin; I. Bouzy; P. Duvillard; A. Ge 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 56 KB

High-dose versus low-dose D-penicillamin

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

✍ Philip J. Clements; Daniel E. Furst; Weng-Kee Wong; Maureen Mayes; Barbara White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

Combined cyclophosphamide, vincristine,

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas : Results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group

✍ Christina Nickenig; Martin Dreyling; Eva Hoster; Michael Pfreundschuh; Lorenz Tr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

## Abstract ## BACKGROUND. In patients with advanced‐stage follicular lymphoma (FL) and mantle cell lymphoma (MCL), conventional chemotherapy remains a noncurative approach, and no major improvement in overall survival has been achieved in recent decades. ## METHODS. The German Low‐Grade Lymphom